(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐
中文名称 | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐 |
---|---|
中文同义词 | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐;化合物 T12889L |
英文名称 | SDZ 220-581 (hydrochloride) |
英文同义词 | SDZ 220-581 (hydrochloride);(S)-alpha-Amino-2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-propanoic acid hydrochloride;(S)-α-Amino-2-chloro-5-(phosphonomethyl)[1,1-biphenyl]-3-propanoic acid hydrochloride;SDZ 220-581 hydrochloride >=98% (HPLC);SDZ 220 581 hydrochloride,SDZ 220581 hydrochloride |
CAS号 | 179411-93-9 |
分子式 | C16H18Cl2NO5P |
分子量 | 406.2 |
EINECS号 | |
相关类别 | |
Mol文件 | 179411-93-9.mol |
结构式 | ![]() |
(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐 性质
储存条件 | room temp |
---|---|
溶解度 | DMSO:可溶5mg/mL,澄清(加热) |
形态 | 粉末 |
颜色 | 白色至米色 |
旋光性 (optical activity) | [α]/D -5 to -8°, c = 1 in 1 M HCl |
SDZ 220-581 hydrochloride 是一种口服生物利用度,有效的竞争性的 NMDA 受体拮抗剂,pKi 值为 7.7。
pKi: 7.7 ( NMDA receptor )
SDZ 220-581 (3.2-32 mg/kg; oral administration; for 24 hours; male OF-l mice) treatment dose-dependently protects mice against maximal electroshock seizures (MES). The time-course of protection by SDZ 220-581 is characterized by a rapid onset and long duration of action.
Animal Model: | Male OF-l mice (18-26 g) |
Dosage: | 3.2 mg/kg, 10 mg/kg, 32 mg/kg |
Administration: | Oral administration; for 24 hours |
Result: | Dose-dependently protected mice against maximal electroshock seizures (MES) upon oral administration. |
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-13059B | SDZ 220-581 hydrochloride | 5 mg | 871元 | |
2024/04/30 | HY-13059B | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐 SDZ 220-581 hydrochloride | 179411-93-9 | 10mg | 1395元 |